TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

U.S. Markets Open Higher; Mannkind, PPG Industries In Focus
Play
INVESTING

Best-Performing Newsletter of 2020

PRESS RELEASES

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating MannKind Corporation For Potential Breaches Of Fiduciary Duty By Its Board Of Directors

European Stocks Fall as Investors React to Trump Immigration Ban
JIM CRAMER

Jobs Plus Earnings Equal Buys: Cramer's 'Mad Money' Recap

Positive Earnings Drive Dow to New Record in Best Performance in a Month
FUTURES

Positive Earnings Drive Dow to New Record in Best Performance in a Month

If the S&P 500 Doesn't Blow Past This Key Value, Look Out Below
FUTURES

Dow Rises 200 Points With Records in Grasp After Caterpillar, 3M Earnings

Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case
MERGERS AND ACQUISITIONS

Pharma Bro Martin Shkreli Waits as Brooklyn Jury Now Has His Fate in Their Hands

Mannkind in Free Fall After Changes to Insulin Product, Sales Force
STOCKS

Mannkind in Free Fall After Changes to Insulin Product, Sales Force

Mannkind Stock Drops Following Changes to Its Insulin Product
VIDEO

Mannkind Stock Drops Following Changes to Its Insulin Product

California Sues Teva, Allergan for Allegedly Blocking Generic Competition to Lidoderm
STOCKS

Laser-maker Cynosure leads biotech movers ahead of market open

2016 Was a Terrible Year for Biotech but the Tweets Were on Point
VIDEO

2016 Was a Terrible Year for Biotech but the Tweets Were on Point

Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)
STOCKS

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

2016 Was a Terrible Year for Biotech but the Tweets Were on Point
STOCKS

2016 was a terrible year for biotech but the tweets were on point

Dow's Worst Performers: NKE, AAPL, MCD, MRK, INTC
INVESTING

These 5 stocks under $10 could make you a lot of money

Mannkind in Free Fall After Changes to Insulin Product, Sales Force
STOCKS

MannKind is still too heavy to avoid the Afrezza crash landing

Here's Why MannKind (MNKD) Stock Is Down Today
MARKETS

What to expect from mannkind's (mnkd) q2 earnings report

Here's Why MannKind (MNKD) Stock Is Down Today
MARKETS

Here's Why MannKind (MNKD) Stock Is Down Today

Here's Why MannKind (MNKD) Stock Is Down Today
STOCKS

MannKind and its CEO fail simple financial literacy test

Here's Why MannKind (MNKD) Stock Is Down Today
MARKETS

MannKind (MNKD) Stock Drops on Q4 Loss

Here's Why MannKind (MNKD) Stock Is Down Today
MARKETS

MannKind (MNKD) Stock Down in After-Hours Trading on Q4 Earnings

Analyst Opinions Split on Fedex (FDX) Despite Q1 Earnings Beat
INVESTING

What's Ahead for the Week: Can FedEx Deliver Strong Results?

What's Ahead for the Week: Can FedEx Deliver a Strong Quarter?
VIDEO

What's Ahead for the Week: Can FedEx Deliver a Strong Quarter?

Here's Why MannKind (MNKD) Stock Is Down Today
MARKETS

MannKind (MNKD) Stock Spiked Ahead of Q4 Earnings

Rockwell Medical's 'Exceptional Year' of Nonexistent Dialysis Drug Sales
STOCKS

Rockwell Medical's 'Exceptional Year' of Nonexistent Dialysis Drug Sales

Here's Why MannKind (MNKD) Stock Is Down Today
STOCKS

MannKind fails Twitter like it does Afrezza

MannKind (MNKD) Stock Skyrocketing on Sale Speculation
MARKETS

MannKind (MNKD) Stock Skyrocketing on Sale Speculation